Sponsored by: Miller Legal LLP

Find out if you qualify for a lawsuit

Contact Us:
(888) 775-3026(888) 775-3026

Januvia Cancer Lawsuit News

Januvia Sales Drop for the Quarter

Sales of Merck’s Januvia, a diabetes medication and the company’s biggest seller, dropped for the first quarter of the year. The news, which was reported May 1, was surprising, Reuters said. Merck also lowered its full-year forecast today. Merck sales for the quarter dropped 9 percent to $10.7 billion, according … read more

Public Citizen Urges FDA to Ban Januvia Because of Cancer Risk

Dr. Sidney Wolfe, Director of Public Citizen’s Health Research Group, issued a statement last month, addressing the risk of precancerous changes in the pancreases of diabetic patients who use diabetes drugs Januvia (sitagliptin), Byetta (exenatide) and Victoza (liraglutide). According to the statement, Drs. Alexandra Butler and Peter Butler of the … read more